معرفی
Dr Emma Scott is a Research Fellow at Newcastle University, focusing on molecular mechanisms in prostate cancer and glycosylation biology. Her work spans genetic regulation, tumor immunology, and metabolic reprogramming.
- Current research explores:
- RNA splicing regulators in cancer aggressiveness
- Glycosylation pathways (ST3Gal1, ST6GAL1, GCNT1, GALNT7)
- Lipid metabolism in castration-resistant prostate cancer
- Immunotherapy resistance mechanisms
Her publications (2017-2025) demonstrate sustained contributions to prostate cancer biology through collaborations with leading oncologists and biochemists like Professor Craig Robson and Professor David Elliott. Key projects include investigating splicing activators (Tra2b), sialylation enzymes, and tumor glycan interactions with immune cells.
Recent work (2024-2025) addresses standardization challenges in sialic acid antibody quantification and expands understanding of post-transcriptional regulatory networks in cancer. She actively contributes to in vitro cancer modeling and epigenetic regulation studies (KMT5A/CDC20 axis).
